世界の進行性核上性麻痺市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Progressive Supranuclear Palsy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5964
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、進行性核上性麻痺の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（初期段階、臨床試験、後期段階、その他）、用途別市場規模（病院、クリニック、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・進行性核上性麻痺の市場動向
・企業の競争状況、市場シェア
・進行性核上性麻痺の種類別市場規模と予測2016-2027（初期段階、臨床試験、後期段階、その他）
・進行性核上性麻痺の用途別市場規模と予測2016-2027（病院、クリニック、研究所、その他）
・進行性核上性麻痺の北米市場規模2016-2027（アメリカ、カナダ）
・進行性核上性麻痺の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・進行性核上性麻痺のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・進行性核上性麻痺の中南米市場規模2016-2027（メキシコ、ブラジル）
・進行性核上性麻痺の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck & Co., Inc.、Aton Pharma, Inc.、Bristol Myers Squibb (BMS)、GlaxoSmithKline plc、Novartis AG、Teva Pharmaceutical Industries Ltd.、AB Science、AbbVie Inc.、AlzProtect SAS、Cortice Biosciences, Inc.、Acorda Therapeutics Inc.、Biogen Inc.）
・結論

Progressive Supranuclear Palsy is a class of neuro-degenerative disorder that affects movement, control of walking and balance, speech, swallowing, vision, mood and behavior, and thinking.

Market Analysis and Insights: Global Progressive Supranuclear Palsy Market
The global Progressive Supranuclear Palsy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Progressive Supranuclear Palsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Progressive Supranuclear Palsy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Progressive Supranuclear Palsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Progressive Supranuclear Palsy market.

Global Progressive Supranuclear Palsy Scope and Market Size
Progressive Supranuclear Palsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Progressive Supranuclear Palsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Early Stage
Clinical Trial
Late Stage
Others

Segment by Application
Hospitals
Clinics
Research Institutes
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck & Co., Inc.
Aton Pharma, Inc.
Bristol Myers Squibb (BMS)
GlaxoSmithKline plc
Novartis AG
Teva Pharmaceutical Industries Ltd.
AB Science
AbbVie Inc.
AlzProtect SAS
Cortice Biosciences, Inc.
Acorda Therapeutics Inc.
Biogen Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Progressive Supranuclear Palsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Early Stage
1.2.3 Clinical Trial
1.2.4 Late Stage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Progressive Supranuclear Palsy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Progressive Supranuclear Palsy Market Perspective (2016-2027)
2.2 Progressive Supranuclear Palsy Growth Trends by Regions
2.2.1 Progressive Supranuclear Palsy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Progressive Supranuclear Palsy Historic Market Share by Regions (2016-2021)
2.2.3 Progressive Supranuclear Palsy Forecasted Market Size by Regions (2022-2027)
2.3 Progressive Supranuclear Palsy Industry Dynamic
2.3.1 Progressive Supranuclear Palsy Market Trends
2.3.2 Progressive Supranuclear Palsy Market Drivers
2.3.3 Progressive Supranuclear Palsy Market Challenges
2.3.4 Progressive Supranuclear Palsy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Progressive Supranuclear Palsy Players by Revenue
3.1.1 Global Top Progressive Supranuclear Palsy Players by Revenue (2016-2021)
3.1.2 Global Progressive Supranuclear Palsy Revenue Market Share by Players (2016-2021)
3.2 Global Progressive Supranuclear Palsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Progressive Supranuclear Palsy Revenue
3.4 Global Progressive Supranuclear Palsy Market Concentration Ratio
3.4.1 Global Progressive Supranuclear Palsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Progressive Supranuclear Palsy Revenue in 2020
3.5 Progressive Supranuclear Palsy Key Players Head office and Area Served
3.6 Key Players Progressive Supranuclear Palsy Product Solution and Service
3.7 Date of Enter into Progressive Supranuclear Palsy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Progressive Supranuclear Palsy Breakdown Data by Type
4.1 Global Progressive Supranuclear Palsy Historic Market Size by Type (2016-2021)
4.2 Global Progressive Supranuclear Palsy Forecasted Market Size by Type (2022-2027)

5 Progressive Supranuclear Palsy Breakdown Data by Application
5.1 Global Progressive Supranuclear Palsy Historic Market Size by Application (2016-2021)
5.2 Global Progressive Supranuclear Palsy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Progressive Supranuclear Palsy Market Size (2016-2027)
6.2 North America Progressive Supranuclear Palsy Market Size by Type
6.2.1 North America Progressive Supranuclear Palsy Market Size by Type (2016-2021)
6.2.2 North America Progressive Supranuclear Palsy Market Size by Type (2022-2027)
6.2.3 North America Progressive Supranuclear Palsy Market Size by Type (2016-2027)
6.3 North America Progressive Supranuclear Palsy Market Size by Application
6.3.1 North America Progressive Supranuclear Palsy Market Size by Application (2016-2021)
6.3.2 North America Progressive Supranuclear Palsy Market Size by Application (2022-2027)
6.3.3 North America Progressive Supranuclear Palsy Market Size by Application (2016-2027)
6.4 North America Progressive Supranuclear Palsy Market Size by Country
6.4.1 North America Progressive Supranuclear Palsy Market Size by Country (2016-2021)
6.4.2 North America Progressive Supranuclear Palsy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Progressive Supranuclear Palsy Market Size (2016-2027)
7.2 Europe Progressive Supranuclear Palsy Market Size by Type
7.2.1 Europe Progressive Supranuclear Palsy Market Size by Type (2016-2021)
7.2.2 Europe Progressive Supranuclear Palsy Market Size by Type (2022-2027)
7.2.3 Europe Progressive Supranuclear Palsy Market Size by Type (2016-2027)
7.3 Europe Progressive Supranuclear Palsy Market Size by Application
7.3.1 Europe Progressive Supranuclear Palsy Market Size by Application (2016-2021)
7.3.2 Europe Progressive Supranuclear Palsy Market Size by Application (2022-2027)
7.3.3 Europe Progressive Supranuclear Palsy Market Size by Application (2016-2027)
7.4 Europe Progressive Supranuclear Palsy Market Size by Country
7.4.1 Europe Progressive Supranuclear Palsy Market Size by Country (2016-2021)
7.4.2 Europe Progressive Supranuclear Palsy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Progressive Supranuclear Palsy Market Size (2016-2027)
8.2 Asia-Pacific Progressive Supranuclear Palsy Market Size by Type
8.2.1 Asia-Pacific Progressive Supranuclear Palsy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Progressive Supranuclear Palsy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Progressive Supranuclear Palsy Market Size by Type (2016-2027)
8.3 Asia-Pacific Progressive Supranuclear Palsy Market Size by Application
8.3.1 Asia-Pacific Progressive Supranuclear Palsy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Progressive Supranuclear Palsy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Progressive Supranuclear Palsy Market Size by Application (2016-2027)
8.4 Asia-Pacific Progressive Supranuclear Palsy Market Size by Region
8.4.1 Asia-Pacific Progressive Supranuclear Palsy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Progressive Supranuclear Palsy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Progressive Supranuclear Palsy Market Size (2016-2027)
9.2 Latin America Progressive Supranuclear Palsy Market Size by Type
9.2.1 Latin America Progressive Supranuclear Palsy Market Size by Type (2016-2021)
9.2.2 Latin America Progressive Supranuclear Palsy Market Size by Type (2022-2027)
9.2.3 Latin America Progressive Supranuclear Palsy Market Size by Type (2016-2027)
9.3 Latin America Progressive Supranuclear Palsy Market Size by Application
9.3.1 Latin America Progressive Supranuclear Palsy Market Size by Application (2016-2021)
9.3.2 Latin America Progressive Supranuclear Palsy Market Size by Application (2022-2027)
9.3.3 Latin America Progressive Supranuclear Palsy Market Size by Application (2016-2027)
9.4 Latin America Progressive Supranuclear Palsy Market Size by Country
9.4.1 Latin America Progressive Supranuclear Palsy Market Size by Country (2016-2021)
9.4.2 Latin America Progressive Supranuclear Palsy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Progressive Supranuclear Palsy Market Size (2016-2027)
10.2 Middle East & Africa Progressive Supranuclear Palsy Market Size by Type
10.2.1 Middle East & Africa Progressive Supranuclear Palsy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Progressive Supranuclear Palsy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Progressive Supranuclear Palsy Market Size by Type (2016-2027)
10.3 Middle East & Africa Progressive Supranuclear Palsy Market Size by Application
10.3.1 Middle East & Africa Progressive Supranuclear Palsy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Progressive Supranuclear Palsy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Progressive Supranuclear Palsy Market Size by Application (2016-2027)
10.4 Middle East & Africa Progressive Supranuclear Palsy Market Size by Country
10.4.1 Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Company Details
11.1.2 Merck & Co., Inc. Business Overview
11.1.3 Merck & Co., Inc. Progressive Supranuclear Palsy Introduction
11.1.4 Merck & Co., Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.1.5 Merck & Co., Inc. Recent Development
11.2 Aton Pharma, Inc.
11.2.1 Aton Pharma, Inc. Company Details
11.2.2 Aton Pharma, Inc. Business Overview
11.2.3 Aton Pharma, Inc. Progressive Supranuclear Palsy Introduction
11.2.4 Aton Pharma, Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.2.5 Aton Pharma, Inc. Recent Development
11.3 Bristol Myers Squibb (BMS)
11.3.1 Bristol Myers Squibb (BMS) Company Details
11.3.2 Bristol Myers Squibb (BMS) Business Overview
11.3.3 Bristol Myers Squibb (BMS) Progressive Supranuclear Palsy Introduction
11.3.4 Bristol Myers Squibb (BMS) Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.3.5 Bristol Myers Squibb (BMS) Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Progressive Supranuclear Palsy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Progressive Supranuclear Palsy Introduction
11.5.4 Novartis AG Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.5.5 Novartis AG Recent Development
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Details
11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd. Progressive Supranuclear Palsy Introduction
11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.7 AB Science
11.7.1 AB Science Company Details
11.7.2 AB Science Business Overview
11.7.3 AB Science Progressive Supranuclear Palsy Introduction
11.7.4 AB Science Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.7.5 AB Science Recent Development
11.8 AbbVie Inc.
11.8.1 AbbVie Inc. Company Details
11.8.2 AbbVie Inc. Business Overview
11.8.3 AbbVie Inc. Progressive Supranuclear Palsy Introduction
11.8.4 AbbVie Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.8.5 AbbVie Inc. Recent Development
11.9 AlzProtect SAS
11.9.1 AlzProtect SAS Company Details
11.9.2 AlzProtect SAS Business Overview
11.9.3 AlzProtect SAS Progressive Supranuclear Palsy Introduction
11.9.4 AlzProtect SAS Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.9.5 AlzProtect SAS Recent Development
11.10 Cortice Biosciences, Inc.
11.10.1 Cortice Biosciences, Inc. Company Details
11.10.2 Cortice Biosciences, Inc. Business Overview
11.10.3 Cortice Biosciences, Inc. Progressive Supranuclear Palsy Introduction
11.10.4 Cortice Biosciences, Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.10.5 Cortice Biosciences, Inc. Recent Development
11.11 Acorda Therapeutics Inc.
11.11.1 Acorda Therapeutics Inc. Company Details
11.11.2 Acorda Therapeutics Inc. Business Overview
11.11.3 Acorda Therapeutics Inc. Progressive Supranuclear Palsy Introduction
11.11.4 Acorda Therapeutics Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.11.5 Acorda Therapeutics Inc. Recent Development
11.12 Biogen Inc.
11.12.1 Biogen Inc. Company Details
11.12.2 Biogen Inc. Business Overview
11.12.3 Biogen Inc. Progressive Supranuclear Palsy Introduction
11.12.4 Biogen Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021)
11.12.5 Biogen Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Progressive Supranuclear Palsy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Early Stage
Table 3. Key Players of Clinical Trial
Table 4. Key Players of Late Stage
Table 5. Key Players of Others
Table 6. Global Progressive Supranuclear Palsy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Progressive Supranuclear Palsy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Progressive Supranuclear Palsy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Progressive Supranuclear Palsy Market Share by Regions (2016-2021)
Table 10. Global Progressive Supranuclear Palsy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Progressive Supranuclear Palsy Market Share by Regions (2022-2027)
Table 12. Progressive Supranuclear Palsy Market Trends
Table 13. Progressive Supranuclear Palsy Market Drivers
Table 14. Progressive Supranuclear Palsy Market Challenges
Table 15. Progressive Supranuclear Palsy Market Restraints
Table 16. Global Progressive Supranuclear Palsy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Progressive Supranuclear Palsy Market Share by Players (2016-2021)
Table 18. Global Top Progressive Supranuclear Palsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progressive Supranuclear Palsy as of 2020)
Table 19. Ranking of Global Top Progressive Supranuclear Palsy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Progressive Supranuclear Palsy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Progressive Supranuclear Palsy Product Solution and Service
Table 23. Date of Enter into Progressive Supranuclear Palsy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Progressive Supranuclear Palsy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Progressive Supranuclear Palsy Revenue Market Share by Type (2016-2021)
Table 27. Global Progressive Supranuclear Palsy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Progressive Supranuclear Palsy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Progressive Supranuclear Palsy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Progressive Supranuclear Palsy Revenue Market Share by Application (2016-2021)
Table 31. Global Progressive Supranuclear Palsy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Progressive Supranuclear Palsy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Progressive Supranuclear Palsy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Progressive Supranuclear Palsy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Progressive Supranuclear Palsy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Progressive Supranuclear Palsy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Progressive Supranuclear Palsy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Progressive Supranuclear Palsy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Progressive Supranuclear Palsy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Progressive Supranuclear Palsy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Progressive Supranuclear Palsy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Progressive Supranuclear Palsy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Progressive Supranuclear Palsy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Progressive Supranuclear Palsy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Progressive Supranuclear Palsy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Progressive Supranuclear Palsy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Progressive Supranuclear Palsy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Progressive Supranuclear Palsy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Progressive Supranuclear Palsy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Progressive Supranuclear Palsy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Progressive Supranuclear Palsy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Progressive Supranuclear Palsy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Progressive Supranuclear Palsy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Progressive Supranuclear Palsy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Progressive Supranuclear Palsy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Progressive Supranuclear Palsy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Progressive Supranuclear Palsy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Progressive Supranuclear Palsy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Progressive Supranuclear Palsy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Progressive Supranuclear Palsy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck & Co., Inc. Company Details
Table 64. Merck & Co., Inc. Business Overview
Table 65. Merck & Co., Inc. Progressive Supranuclear Palsy Product
Table 66. Merck & Co., Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 67. Merck & Co., Inc. Recent Development
Table 68. Aton Pharma, Inc. Company Details
Table 69. Aton Pharma, Inc. Business Overview
Table 70. Aton Pharma, Inc. Progressive Supranuclear Palsy Product
Table 71. Aton Pharma, Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 72. Aton Pharma, Inc. Recent Development
Table 73. Bristol Myers Squibb (BMS) Company Details
Table 74. Bristol Myers Squibb (BMS) Business Overview
Table 75. Bristol Myers Squibb (BMS) Progressive Supranuclear Palsy Product
Table 76. Bristol Myers Squibb (BMS) Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 77. Bristol Myers Squibb (BMS) Recent Development
Table 78. GlaxoSmithKline plc Company Details
Table 79. GlaxoSmithKline plc Business Overview
Table 80. GlaxoSmithKline plc Progressive Supranuclear Palsy Product
Table 81. GlaxoSmithKline plc Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 82. GlaxoSmithKline plc Recent Development
Table 83. Novartis AG Company Details
Table 84. Novartis AG Business Overview
Table 85. Novartis AG Progressive Supranuclear Palsy Product
Table 86. Novartis AG Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 87. Novartis AG Recent Development
Table 88. Teva Pharmaceutical Industries Ltd. Company Details
Table 89. Teva Pharmaceutical Industries Ltd. Business Overview
Table 90. Teva Pharmaceutical Industries Ltd. Progressive Supranuclear Palsy Product
Table 91. Teva Pharmaceutical Industries Ltd. Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 92. Teva Pharmaceutical Industries Ltd. Recent Development
Table 93. AB Science Company Details
Table 94. AB Science Business Overview
Table 95. AB Science Progressive Supranuclear Palsy Product
Table 96. AB Science Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 97. AB Science Recent Development
Table 98. AbbVie Inc. Company Details
Table 99. AbbVie Inc. Business Overview
Table 100. AbbVie Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 101. AbbVie Inc. Recent Development
Table 102. AlzProtect SAS Company Details
Table 103. AlzProtect SAS Business Overview
Table 104. AlzProtect SAS Progressive Supranuclear Palsy Product
Table 105. AlzProtect SAS Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 106. AlzProtect SAS Recent Development
Table 107. Cortice Biosciences, Inc. Company Details
Table 108. Cortice Biosciences, Inc. Business Overview
Table 109. Cortice Biosciences, Inc. Progressive Supranuclear Palsy Product
Table 110. Cortice Biosciences, Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 111. Cortice Biosciences, Inc. Recent Development
Table 112. Acorda Therapeutics Inc. Company Details
Table 113. Acorda Therapeutics Inc. Business Overview
Table 114. Acorda Therapeutics Inc. Progressive Supranuclear Palsy Product
Table 115. Acorda Therapeutics Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 116. Acorda Therapeutics Inc. Recent Development
Table 117. Biogen Inc. Company Details
Table 118. Biogen Inc. Business Overview
Table 119. Biogen Inc. Progressive Supranuclear Palsy Product
Table 120. Biogen Inc. Revenue in Progressive Supranuclear Palsy Business (2016-2021) & (US$ Million)
Table 121. Biogen Inc. Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Progressive Supranuclear Palsy Market Share by Type: 2020 VS 2027
Figure 2. Early Stage Features
Figure 3. Clinical Trial Features
Figure 4. Late Stage Features
Figure 5. Others Features
Figure 6. Global Progressive Supranuclear Palsy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Progressive Supranuclear Palsy Report Years Considered
Figure 12. Global Progressive Supranuclear Palsy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Progressive Supranuclear Palsy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Progressive Supranuclear Palsy Market Share by Regions: 2020 VS 2027
Figure 15. Global Progressive Supranuclear Palsy Market Share by Regions (2022-2027)
Figure 16. Global Progressive Supranuclear Palsy Market Share by Players in 2020
Figure 17. Global Top Progressive Supranuclear Palsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Progressive Supranuclear Palsy as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Progressive Supranuclear Palsy Revenue in 2020
Figure 19. Global Progressive Supranuclear Palsy Revenue Market Share by Type (2016-2021)
Figure 20. Global Progressive Supranuclear Palsy Revenue Market Share by Type (2022-2027)
Figure 21. North America Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Progressive Supranuclear Palsy Market Share by Type (2016-2027)
Figure 23. North America Progressive Supranuclear Palsy Market Share by Application (2016-2027)
Figure 24. North America Progressive Supranuclear Palsy Market Share by Country (2016-2027)
Figure 25. United States Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Progressive Supranuclear Palsy Market Share by Type (2016-2027)
Figure 29. Europe Progressive Supranuclear Palsy Market Share by Application (2016-2027)
Figure 30. Europe Progressive Supranuclear Palsy Market Share by Country (2016-2027)
Figure 31. Germany Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Progressive Supranuclear Palsy Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Progressive Supranuclear Palsy Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Progressive Supranuclear Palsy Market Share by Region (2016-2027)
Figure 41. China Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Progressive Supranuclear Palsy Market Share by Type (2016-2027)
Figure 49. Latin America Progressive Supranuclear Palsy Market Share by Application (2016-2027)
Figure 50. Latin America Progressive Supranuclear Palsy Market Share by Country (2016-2027)
Figure 51. Mexico Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Progressive Supranuclear Palsy Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Progressive Supranuclear Palsy Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Progressive Supranuclear Palsy Market Share by Country (2016-2027)
Figure 57. Turkey Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Progressive Supranuclear Palsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Merck & Co., Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 61. Aton Pharma, Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 62. Bristol Myers Squibb (BMS) Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 63. GlaxoSmithKline plc Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 64. Novartis AG Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 65. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 66. AB Science Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 67. AbbVie Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 68. AlzProtect SAS Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 69. Cortice Biosciences, Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 70. Acorda Therapeutics Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 71. Biogen Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の脳性麻痺治療市場規模・現状・予測（2021年-2027年）

Global Cerebral Palsy Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3996 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、脳性麻痺治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科治療、投薬、栄養療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の進行性家族性肝内胆汁うっ滞症2型治療市場規模・現状・予測（2021年-2027年）

Global Progressive Familial Intrahepatic Cholestasis Type 2 Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5963 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、進行性家族性肝内胆汁うっ滞症2型治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ウルソデオキシコール酸、コレスチラミン、リファンピシン、後期パイプライン薬、その他）、用途別市場規模（病院薬局、小売...

世界の個人自動車保険市場規模・現状・予測（2021年-2027年）

Global Personal Auto Insurance Market Size, Status and Forecast 2021-2027
QFJ1-2261 2021年6月 128Pages
QYResearch社発行の本調査レポートでは、個人自動車保険の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（義務保険、任意保険）、用途別市場規模（自動車、トラック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の臍帯血幹細胞バンク市場規模・現状・予測（2021年-2027年）

Global Cord Stem Cell Banking Market Size, Status and Forecast 2021-2027
QFJ1-4056 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、臍帯血幹細胞バンクの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（臍帯血、臍帯血）、用途別市場規模（脳性麻痺、白血病、サラセミア、貧血、自閉症、糖尿病、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の発達性＆てんかん性脳症（DEE）市場規模・現状・予測（2021年-2027年）

Global Developmental and Epileptic Encephalopathies (DEE) Market Size, Status and Forecast 2021-2027
QFJ1-4117 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、発達性＆てんかん性脳症（DEE）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小児用非定型良性部分てんかん、ドラベト症候群、徐波睡眠時連続スパイク・アンド・ウェーブ発生型てんかん、視床下部てんかん、...

世界のレタパムリン市場規模・現状・予測（2021年-2027年）

Global Retapamulin Market Size, Status and Forecast 2021-2027
QFJ1-5992 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、レタパムリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（1％軟膏（15グラムチューブ）、1％軟膏（30グラムチューブ））、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ...

世界のチプラナビル市場規模・現状・予測（2021年-2027年）

Global Tipranavir Market Size, Status and Forecast 2021-2027
QFJ1-6043 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、チプラナビルの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口液剤、カプセル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界のヒストレリン市場規模・現状・予測（2021年-2027年）

Global Histrelin Market Size, Status and Forecast 2021-2027
QFJ1-5781 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ヒストレリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サプレリンLA、ヴァンタス）、用途別市場規模（男の子用、女の子用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界のアニデュラファンギン市場規模・現状・予測（2021年-2027年）

Global Anidulafungin Market Size, Status and Forecast 2021-2027
QFJ1-5581 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アニデュラファンギンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（50mg/各バイアル、100mg/各バイアル）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の脳性麻痺治療市場規模・現状・予測（2021年-2027年） Cerebral palsy (CP) is a group of permanent movement disorders that appear in early childhood. Signs and symptoms vary among people. Often, symptoms include poor coordination, stiff muscles, weak muscles, and tremors. There may be problems with sensation, vision, hearing, swallowing, and speaking. O…
世界の後期慢性腎臓病治療薬市場規模・現状・予測（2021年-2027年） Late stage chronic kidney disease therapeutics can be defined as the drugs which are used for the treatment of late-stage CKD - Induced, Hyperphosphatemia, Hyperparathyroidism and Hyperkalemia. Market Analysis and Insights: Global Late Stage Chronic Kidney Disease Drugs Market The global Late Stage …
世界の進行性家族性肝内胆汁うっ滞症2型治療市場規模・現状・予測（2021年-2027年） Progressive familial intrahepatic cholestasis (PFIC) type 2 is a rare genetic disorder that has no curative medication. Key players in the market only provide symptomatic treatment drugs. Market Analysis and Insights: Global Progressive Familial Intrahepatic Cholestasis Type 2 Treatment Market The g…
世界の腫瘍臨床試験市場規模・現状・予測（2021年-2027年） Clinical trials are the final step in a long process that begins with research in a lab. Oncology trials are predominantly early-phase studies that evaluate surrogate end points and are small, single arm, and open label. Market Analysis and Insights: Global Oncology Clinical Trial Market The global …
世界の末期腎疾患治療市場規模・現状・予測（2021年-2027年） Any condition that causes reduced kidney function leads to chronic kidney disease (CKD), which may develop over a period and lead to end stage renal disease (ESRD), where kidney can no longer function on their own. It is also termed as kidney or renal failure. Factors contributing to the formation o…